Immunoglobulin G Deficiency 

  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Michael A Kaliner, MD   more...
 
Updated: May 1, 2012
 

Background

Immunodeficiency diseases are commonly classified into disorders that affect one or more of the 4 major limbs of the immune system. These limbs are (1) B cells, ie, humoral immunity; (2) T cells, ie, cell-mediated immunity; (3) phagocytes; and (4) complement.

B-cell immunity is mediated by the immunoglobulins and is commonly referred to as humoral immunity. Humoral immunity is differentiated from T-cell immunity, which is commonly referred to as cellular immunity, and from phagocytic cell immune function. Immunoglobulins, which are protein molecules that contain antibody activity, are produced by the terminal cells of B-cell differentiation known as plasma cells. Immunoglobulins have important roles in humoral immunity, and they consist of 5 major classes or isotypes: immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), immunoglobulin D (IgD), and immunoglobulin E (IgE). The most abundant class of immunoglobulins in the blood is IgG (73%), which has a molecular weight of 150 kd. IgG is present in plasma and external secretions and is expressed on the B-cell membrane.

Immunoglobulin G deficiency. Schematic representatImmunoglobulin G deficiency. Schematic representation of an immunoglobulin G molecule. CH indicates constant region of heavy chain; CL, constant region of light chain; VH, variable region of heavy chain; and VL, variable region of light chain.

IgG is further subdivided into 4 subclasses: IgG1, IgG2, IgG3, and IgG4. Fortunately, for ease of recall, the serum concentrations of the subclasses directly correlate with their numerical nomenclature, such that IgG1 is found in greater concentrations than IgG2, and so forth.

Immunoglobulin G deficiency. Human immunoglobulin Immunoglobulin G deficiency. Human immunoglobulin G subclasses.

In 1952, Bruton described classic X-linked agammaglobulinemia due to B-cell deficiency in an 8-year-old boy. The child presented with frequent pyogenic infections, repeated episodes of sepsis with the same serotypes of pneumococcus, and multiple episodes of mumps, yet he had no antibodies against these pathogens. Serum protein electrophoresis had just become available, and it revealed that the g fraction was missing from the child’s blood.. Subsequently, patients were described who had detectable lymphoid tissue and B-cells but had decreased IgG levels and/or lacked specific antibodies. These conditions are now recognized as fitting the categories of hyper-IgM syndromes and common variable immunodeficiency (CVID).

In the early 1960s, following the discovery of the IgG subclasses, certain associations were also recognized between individual subclass deficiencies, decreased ability to respond to certain types of antigens (ie, bacterial polysaccharides), and recurrent infection. IgG deficiencies may occur as isolated deficiencies (eg, selective IgG deficiency) or in association with deficiencies of other immunoglobulin types. Moreover, even if the total IgG concentration is normal, deficiencies of one or more individual IgG subclasses, significant decreases in specific IgG antibodies, or both may be observed.

For information on deficiencies of other immunoglobulin types, see the Medscape Reference articles IgA Deficiency, IgD Deficiency, and IgM Deficiency.

Next

Pathophysiology

B and T cells are responsible for specific immunity, otherwise known as adaptive immunity. Adaptive immune responses require rearrangement of the genes responsible for the specific recognition structures, ie, immunoglobulins for humoral immunity and T-cell receptors for cellular immunity. Inability to form these recognition structures or blocks in the differentiation and development of either of these cell types results in primary immune deficiency. Abnormal production of these cells may also be observed in clinical states in which production of abnormal cell types is pathologically excessive (eg, lymphoproliferative diseases such as lymphoma and leukemia) or in immunodeficiency disorders in which production is aberrantly low.[1] Humoral immune defects can also result from excessive loss of antibody proteins (eg, protein-losing enteropathy, certain forms of nephritis), even though the B-cell mass may be normal in those conditions.

IgG is well distributed in intravascular and extravascular spaces and is important in the secondary antibody responses (immune memory). It plays an important role in host defense against infection. IgG protects tissues from bacteria, viruses, and toxins. Different subclasses of IgG neutralize bacterial toxins, activate complement, and enhance phagocytosis by opsonization.[2]

Importantly, note that a low IgG level, with normal IgA and IgM levels, does not necessarily equate with antibody deficiency. The evaluation of specific antibody responses is essential for the diagnosis and for appropriate treatment.

For ease of discussion, IgG deficiencies may be divided into 2 categories. The first is selective IgG deficiency, which consists of an isolated deficiency of IgG with normal levels of IgA, IgM, IgD, and IgE. The second is a deficiency of IgG accompanied by inadequate levels of other immunoglobulin isotypes. This may occur in various conditions, including X-linked agammaglobulinemia (X-LA), common variable immunodeficiency (CVID), and hyper-IgM syndromes.

These disorders occur in persons of any age or sex. Selective immunoglobulin deficiencies were previously referred to as late-onset agammaglobulinemia, and now they are classified under the general designation of antibody deficiency. Both pediatric and adult populations may be affected by specific or selective antibody deficiencies, CVID, or both. See Common variable immunodeficiency for more details.

IgA deficiency is the most common immune deficiency. Although some "normal" blood donors may be found to be deficient in IgA, approximately 20% of patients who lack IgA are also deficient in IgG2 and IgG4. These individuals appear to have a greater risk of infection than patients with isolated IgA deficiency.

Previous
Next

Epidemiology

Frequency

United States

Although the frequency of isolated IgG deficiency is not known with certainty, deficiencies in specific IgG antibody or IgG subclass is probably more common and occurs in families with common variable immunodeficiency (CVID). Some reports indicate that the prevalence of IgG deficiency may be 1 case per 10,000 persons.

Mortality/Morbidity

  • Early diagnosis and treatment of IgG deficiency is essential to prevent and control both morbidity and mortality.
  • IgG subclass levels are highly variable, even within individuals at different points in time. Their development in early childhood varies from subclass to subclass; IgG 2 is the slowest to reach adult values. Additional deficiencies may become apparent because of defective switching between different IgG subclasses.

Sex

  • Males and females are affected.

Age

Both children and adults are affected. Children younger than 24 months cannot make much IgG2; hence, measuring the IgG2 subclass concentration before this age is not meaningful.

The most common subclass deficiency in early childhood is IgG2 deficiency; in adults, IgG1 and IgG3 deficiencies predominate. IgG1 accounts for a higher proportion of the total IgG in children as compared to adults. Although children rapidly attain adult levels of IgG1 and IgG3, the development of IgG2 and IgG4 is slower. In some children, maturation of the full range of IgG subclasses may be delayed until the teenage years. Note the figure below.

Immunoglobulin G deficiency. Changes in serum immuImmunoglobulin G deficiency. Changes in serum immunoglobulin G concentrations during infancy and childhood.

One recent study found an isolated IgG3 subclass deficiency was the most common IgG subclass deficiency in Thai children. IgG3 subclass deficiency, either isolated or combined with other IgG subclass deficiency, was found in 85.5% of 55 children, most of whom were first evaluated for recurrent sinusitis.[3]

Previous
Proceed to Clinical Presentation
 
 
Contributor Information and Disclosures
Author

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

Robert Y Lin, MD  Professor, Department of Medicine, New York Medical College; Chief, Allergy and Immunology, and Director of Utilization Review, Department Medicine, New York Downtown Hospital

Robert Y Lin, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology and New York Allergy & Asthma Society

Disclosure: Nothing to disclose.

Janet Vafaie, MD  Private Practice

Disclosure: Nothing to disclose.

Specialty Editor Board

Melvin Berger, MD, PhD  Adjunct Professor of Pediatrics and Pathology, Case Western Reserve University; Senior Medical Director, Clinical Research and Development, CSL Behring, LLC

Melvin Berger, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Clinical Investigation, and Clinical Immunology Society

Disclosure: CSL Behring Salary Employment; CSL Behring Ownership interest Employment; America's Health insurance plans Consulting fee Subject Matter Expert For Clinical Immunization Safety Assessment Network acvtivity of CDC

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Michael R Simon, MD, MA  Clinical Professor Emeritus, Departments of Internal Medicine and Pediatrics, Wayne State University School of Medicine; Professor, Department of Internal Medicine, Oakland University William Beaumont University School of Medicine; Adjunct Staff, Division of Allergy and Immunology, Department of Internal Medicine, William Beaumont Hospital

Michael R Simon, MD, MA is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Allergy, Asthma and Immunology, American College of Physicians, American Federation for Medical Research, Michigan Allergy and Asthma Society, Michigan State Medical Society, Royal College of Physicians and Surgeons of Canada, and Society for Experimental Biology and Medicine

Disclosure: Secretory IgA, Inc. Ownership interest Management position

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Michael A Kaliner, MD  Clinical Professor of Medicine, George Washington University School of Medicine; Chief, Section of Allergy and Immunology, Washington Hospital Center; Medical Director, Institute for Asthma and Allergy

Michael A Kaliner, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association of Immunologists, American College of Allergy, Asthma and Immunology, American Society for Clinical Investigation, American Thoracic Society, and Association of American Physicians

Disclosure: Alcon Consulting fee Consulting; Teva Consulting fee Consulting; Meda Honoraria Speaking and teaching; Ista Consulting fee Consulting; sunovian Consulting fee Consulting; dey Honoraria Review panel membership

References

  1. Yong PF, Chee R, Grimbacher B. Hypogammaglobulinaemia. Immunol Allergy Clin North Am. Nov 2008;28(4):691-713. [Medline].

  2. Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Treatment. Vol 12. 17th ed. Whitehouse Station, NJ: Merck & Co; 2004.

  3. Visitsunthorn N, Hengcrawit W, Jirapongsananuruk O, Luangwedchakam V. Immunoglobulin G (IgG) subclass deficiency in Thai children. Asian Pac J Allergy Immunol. Dec 2011;29(4):332-7. [Medline].

  4. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. Mar 27 2009;[Medline].

  5. Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. Sep 2007;99(3):281-3. [Medline].

  6. Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol. Nov 2007;99(5):462-4. [Medline].

  7. Chouksey AK, Berger M. Assessment of protein antibody response in patients with suspected immune deficiency. Ann Allergy Asthma Immunol. Feb 2008;100(2):166-8. [Medline].

  8. Aucouturier P, Lacombe C, Bremard C, et al. Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infections. Clin Immunol Immunopathol. Apr 1989;51(1):22-37. [Medline].

  9. Sikora AG, Lee KC. Otolaryngologic Manifestations of Immunodeficiency. In: Otolaryngologic Clinics of North America. Vol 36. Philadelphia, Pa: WB Saunders; 2003:647.

  10. Heiner DC, Myers A, Beck CS. Deficiency of IgG4: a disorder associated with frequent infections and bronchiectasis that may be familial. Clin Rev Allergy. Jun 1983;1(2):259-66. [Medline].

  11. Jain A, Atkinson TP, Lipsky PE, et al. Defects of T-cell effector function and post-thymic maturation in X- linked hyper-IgM syndrome. J Clin Invest. Apr 1999;103(8):1151-8. [Medline].

  12. Khvatova AV, Skriabina OA, Kargina IB, et al. [Immunodiagnosis of retinoblastoma]. Vestn Oftalmol. May-Jun 1992;108(3):34-6. [Medline].

  13. Caksen H, Oner AF, Arslan S, et al. Immunoglobulin subgroups in children with febrile seizures. Pediatr Int. Feb 2001;43(1):58-60. [Medline].

  14. Ojuawo A, Milla PJ, Lindley KJ. Serum immunoglobulin and immunoglobulin G subclasses in children with allergic colitis. West Afr J Med. Jul-Sep 1998;17(3):206-9. [Medline].

  15. Ojuawo A, St Louis D, Lindley KJ. Non-infective colitis in infancy: evidence in favour of minor immunodeficiency in its pathogenesis. Arch Dis Child. Apr 1997;76(4):345-8. [Medline].

  16. Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy?. Curr Allergy Asthma Rep. Sep 2002;2(5):356-60. [Medline].

  17. Stiehm ER. The four most common pediatric immunodeficiencies. J Immunotoxicol. Apr 2008;5(2):227-34. [Medline].

  18. Adkinson NF. B Cell Immunodeficiency. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER. Middleton's Allergy: Principles and Practice. 6th ed. St. Louis, Mo: Mosby; 2004:1062-7.

  19. Abdou NI, Greenwell CA, Mehta R, Narra M, Hester JD, Halsey JF. Efficacy of Intravenous Gammaglobulin for Immunoglobulin G Subclass and/or Antibody Deficiency in Adults. Int Arch Allergy Immunol. Feb 12 2009;149(3):267-274. [Medline].

  20. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles & Practice of Infectious Diseases. Vol 1. 5th ed. New York, NY: Churchhill Livingston; 2000:59-61.

  21. Nicolay U, Kiessling P, Berger M, et al. Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol. Jan 2006;26(1):65-72. [Medline].

  22. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am. May 2008;28(2):413-37, x. [Medline].

  23. Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev. Oct 2003;17(4):241-51. [Medline].

  24. Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. Apr 2006;117(4 Suppl):S525-53. [Medline].

  25. Berger M. Subcutaneous administration of IgG. Immunol Allergy Clin North Am. Nov 2008;28(4):779-802, viii. [Medline].

  26. Ochs HD, Gupta S, Kiessling P, Nicolay U, Berger M. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol. May 2006;26(3):265-73. [Medline].

  27. Gathmann B, Binder N, Ehl S, Kindle G. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. Mar 2012;167(3):479-91. [Medline].

  28. Ekdahl K, Braconier JH, Svanborg C. Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection. Clin Infect Dis. Sep 1997;25(3):654-60. [Medline].

  29. Ferrari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. Oct 23 2001;98(22):12614-9. [Medline].

  30. Gleeson M, McDonald WA, Cripps AW, et al. The effect on immunity of long-term intensive training in elite swimmers. Clin Exp Immunol. Oct 1995;102(1):210-6. [Medline].

  31. Guneser S, Antmen B, Altintas D, Yilmaz M. The frequency of IgG subclass deficiency in children with recurrent respiratory infections. Turk J Pediatr. Apr-Jun 1996;38(2):161-8. [Medline].

  32. Hamilos DL, Young RM, Peter JB, et al. Hypogammaglobulinemia in asthmatic patients. Ann Allergy. Jun 1992;68(6):472-81. [Medline].

  33. Hoffman R. Antibody Deficiencies. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P. Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill Livingstone; 2000:765-70.

  34. Imai K, Catalan N, Plebani A, et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest. Jul 2003;112(1):136-42. [Medline].

  35. Inoue R, Kondo N, Kobayashi Y, et al. IgG2 deficiency associated with defects in production of interferon- gamma; comparison with common variable immunodeficiency. Scand J Immunol. Feb 1995;41(2):130-4. [Medline].

  36. Lacombe C, Aucouturier P, Preud'homme JL. Selective IgG1 deficiency. Clin Immunol Immunopathol. Aug 1997;84(2):194-201. [Medline].

  37. Lassoued K, Oksenhendler E, Lambin JP, et al. Severe neutropenia associated with IgG2 subclass deficiency and bone marrow T-lymphocyte infiltration. Am J Hematol. Mar 1998;57(3):241-4. [Medline].

  38. May A, Zielen S, Reimold I, et al. [Immunoglobulin subclass defects in patients with therapy refractor chronic rhinosinusitis]. HNO. Jan 1999;47(1):19-24. [Medline].

  39. Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2000.

  40. Roifman CM, Schroeder H, Berger M, et al. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. Int Immunopharmacol. Sep 2003;3(9):1325-33. [Medline].

  41. Sakiyama Y, Komiyama A, Shiraki K, et al. [Intravenous immunoglobulin (GB-0998) for prophylaxis of recurrent acute otitis media and lower respiratory tract infection in infancy with IgG 2 deficiency]. Nihon Rinsho Meneki Gakkai Kaishi. Apr 1998;21(2):70-9. [Medline].

  42. Sandler SG, Trimble J, Mallory DM. Coexistent IgG2 and IgA deficiencies in blood donors. Transfusion. Mar 1996;36(3):256-8. [Medline].

  43. Sekerel BE, Saraclar Y, Sanal O, et al. IgG subclasses in children with recurrent respiratory tract infections in an allergy practice. Acta Paediatr Jpn. Apr 1996;38(2):124-7. [Medline].

  44. Shackelford PG, Granoff DM, Madassery JV, et al. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res. Jan 1990;27(1):16-21. [Medline].

  45. Shephard RJ, Rhind S, Shek PN. The impact of exercise on the immune system: NK cells, interleukins 1 and 2, and related responses. Exerc Sport Sci Rev. 1995;23:215-41. [Medline].

  46. Smith LJ, Szymanski W, Foulston C, et al. Familial enteropathy with villous edema and immunoglobulin G2 subclass deficiency. J Pediatr. Oct 1994;125(4):541-8. [Medline].

  47. Snowden JA, Milford-Ward A, Reilly JT. Symptomatic IgG3 deficiency successfully treated with intravenous immunoglobulin therapy. Postgrad Med J. Dec 1994;70(830):924-6. [Medline].

  48. Tezcan I, Ersoy F, Sanal O, et al. IgG subclass deficiency in children with recurrent infections. Turk J Pediatr. Jul-Sep 1991;33(3):163-6. [Medline].

  49. Travin M, Macris NT, Block JM, Schwimmer D. Reversible common variable immunodeficiency syndrome induced by phenytoin. Arch Intern Med. Jun 1989;149(6):1421-2. [Medline].

  50. Tsujihata M, Satoh A, Yoshimura T, et al. Effect of myasthenic immunoglobulin G on motor end-plate morphology. J Neurol. Jan 2003;250:75-82. [Medline].

  51. Van Kessel DA, Horikx PE, Van Houte AJ, et al. Clinical and immunological evaluation of patients with mild IgG1 deficiency. Clin Exp Immunol. Oct 1999;118(1):102-7. [Medline].

 
Previous
Next
 
Immunoglobulin G deficiency. Schematic representation of an immunoglobulin G molecule. CH indicates constant region of heavy chain; CL, constant region of light chain; VH, variable region of heavy chain; and VL, variable region of light chain.
Immunoglobulin G deficiency. Human immunoglobulin G subclasses.
Immunoglobulin G deficiency. Changes in serum immunoglobulin G concentrations during infancy and childhood.
Immunoglobulin G deficiency. Schematic representation of the molecular interaction of CD40 on B cells, with CD40L on T cells involved in the switch from immunoglobulin M to immunoglobulin G.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.